Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析

◆英語タイトル:Alembic Pharmaceuticals Ltd (APLLTD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15095
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antibacterial, cardiovascular, gynecological, cough and cold, gastroenterological, ophthalmological, anti-diabetic, orthopedic, urology, antihistamine, dermatological and herbal nutraceuticals. APL provides generic formulations such as anti-allergic, anthelmintic, antimicrobials, antiulcerants, nutritional and vitamin preparations, and others speciality products. The company has its research centres and manufacturing facilities in Vadodara, Gujarat and Baddi. APL is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Ltd Key Recent Developments

Feb 20,2019: Alembic Pharmaceuticals announces USFDA Approval for Acetazolamide ExtendedRelease Capsules, 500 mg
Feb 15,2019: Alembic Pharmaceuticals announces USFDA Approval for Moxifloxacin Ophthalmic Solution USP 1 0.5%
Feb 11,2019: Alembic Pharmaceuticals announces completion of USFDA inspection at Aleor Dermaceuticals
Jan 22,2019: Alembic Pharmaceuticals announced resignation of Mr Milin Mehta as Independent Director
Dec 19,2018: Alembic Pharmaceuticals announces successful US FDA inspection at its API facility at Panelav

This comprehensive SWOT profile of Alembic Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alembic Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Alembic Pharmaceuticals Ltd – Key Information
Alembic Pharmaceuticals Ltd – Overview
Alembic Pharmaceuticals Ltd – Key Employees
Alembic Pharmaceuticals Ltd – Key Employee Biographies
Alembic Pharmaceuticals Ltd – Key Operational Heads
Alembic Pharmaceuticals Ltd – Major Products and Services
Alembic Pharmaceuticals Ltd – History
Alembic Pharmaceuticals Ltd – Company Statement
Alembic Pharmaceuticals Ltd – Locations And Subsidiaries
Alembic Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Alembic Pharmaceuticals Ltd – Business Description
Alembic Pharmaceuticals Ltd – Corporate Strategy
Alembic Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Alembic Pharmaceuticals Ltd – Strengths
Alembic Pharmaceuticals Ltd – Weaknesses
Alembic Pharmaceuticals Ltd – Opportunities
Alembic Pharmaceuticals Ltd – Threats
Alembic Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Alembic Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Alembic Pharmaceuticals Ltd, Key Information
Alembic Pharmaceuticals Ltd, Key Ratios
Alembic Pharmaceuticals Ltd, Share Data
Alembic Pharmaceuticals Ltd, Major Products and Services
Alembic Pharmaceuticals Ltd, History
Alembic Pharmaceuticals Ltd, Key Employees
Alembic Pharmaceuticals Ltd, Key Employee Biographies
Alembic Pharmaceuticals Ltd, Key Operational Heads
Alembic Pharmaceuticals Ltd, Other Locations
Alembic Pharmaceuticals Ltd, Subsidiaries
Alembic Pharmaceuticals Ltd, Key Manufacturing facilities
Alembic Pharmaceuticals Ltd, Key Competitors
Alembic Pharmaceuticals Ltd, SWOT Analysis
Alembic Pharmaceuticals Ltd, Ratios based on current share price
Alembic Pharmaceuticals Ltd, Annual Ratios
Alembic Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Alembic Pharmaceuticals Ltd, Performance Chart
Alembic Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • MEDICREA Group (ALMED):医療機器:M&Aディール及び事業提携情報
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • Ghent University-製薬・医療分野:企業M&A・提携分析
    Summary Ghent University (Ghent) is an educational institution that provides research-based educational programmes and services. The university provides educational services such as international courses, preparatory language courses, programmes for exchange students and language courses, among othe …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務分析
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • Dare Bioscience Inc (DARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Verathon Inc:企業の戦略的SWOT分析
    Verathon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CeraPedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CeraPedics Inc (Cerapedics) is a medical device company that develops and commercializes novel osteobiologic products. The company’s products include i-factor putty, a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to i …
  • James Latham Plc (LTHM):企業の財務・戦略的SWOT分析
    James Latham Plc (LTHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • I-Sens Inc (099190):企業の製品パイプライン分析2018
    Summary I-Sens Inc (I-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise electrolyte and gas analyzers, blood glucose monitoring systems, immuno sensors and accessories, among others. It provides its blood monitoring syst …
  • Printpack, Inc.:企業の戦略・SWOT・財務情報
    Printpack, Inc. - Strategy, SWOT and Corporate Finance Report Summary Printpack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bharat Road Network Limited (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Limited (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tuesday Morning Corporation:企業の戦略・SWOT・財務情報
    Tuesday Morning Corporation - Strategy, SWOT and Corporate Finance Report Summary Tuesday Morning Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務分析
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • KACO new energy GmbH:企業の戦略的SWOT分析
    KACO new energy GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • McDermott International Inc (MDR):電力:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • Nippon Shinyaku Co Ltd (4516):製薬・医療:M&Aディール及び事業提携情報
    Summary Nippon Shinyaku Co Ltd (Nippon) is a pharmaceutical company that develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; ga …
  • Pt Sarihusada Generasi Mahardhika:企業の戦略・SWOT・財務情報
    Pt Sarihusada Generasi Mahardhika - Strategy, SWOT and Corporate Finance Report Summary Pt Sarihusada Generasi Mahardhika - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cadent Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Cadent Therapeutics (Cadent), formerly Luc Therapeutics Inc, is a precision neuroscience company that offers medicines for serious neurological diseases. The company's products comprise NR2B positive allosteric modulators, NR2A negative allosteric modulators and NR2B negative allosteric modu …
  • Perfint Healthcare Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products on onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a Computed Tomography system; ROBIO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆